3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Recurrence
2
Ovarian Neoplasms
2
Hemorrhage
2
Chronic Pain
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Seizures
1
Radiodermatitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Parathyroid Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Interventions
relugolix
8
ulipristal acetate
7
telapristone acetate
7
estradiol, norethindrone drug combination
7
vilaprisan
6
asoprisnil
6
Estradiol
5
linzagolix
4
elagolix
4
Norethindrone Acetate
3
Leuprolide
3
Sugars
2
Progestins
2
epigallocatechin gallate
1
Uterine Myomectomy
1
Uterine Artery Embolization
1
Tranexamic Acid
1
Tea
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Misoprostol
1
Mifepristone
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Laparoscopy
1
Iron
1
Hysterectomy
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Leiomyoma
×
Sodium Chloride
×
Clear all
NCT04655144
2026-01-07
Dex-Fib
University of Miami
Phase 3
Completed
42 enrolled
9 charts